Insulin binding to the cardiopulmonary bypass biomaterials

Urban, Kristyn; Redford, Daniel; Larson, Douglas F.
May 2007
Perfusion;May2007, Vol. 22 Issue 3, p207
Academic Journal
Hyperglycemia associated with cardiopulmonary bypass (CPB) is an independent predictor of morbidity and mortality. One suggested cause of hyperglycemia during CPB is a decline of serum insulin concentrations. Since plasma C-proteins are not reduced during CPB - suggesting that pancreatic insulin secretion is not affected - the reduction of insulin concentrations is hypothesized to be due to the binding of the insulin protein to the CPB biomaterials. The hypothesis of this study is that insulin binds to the CPB polyvinyl chloride (PVC) tubing and that selected bio-coatings inhibit this process. Human insulin was diluted to a physiologic concentration of 30 μU/mL in saline and exposed to four types of sterile PVC tubing, namely: uncoated, Terumo X-coated, Medtronic Carmeda, and Cobe SMARxT for 30 minutes at 37°C. Insulin concentrations were determined with ELISA. The recovered insulin concentrations were found to be 9.3 ± 0.6 μU/mL in the uncoated (control), 17.7 ± 1.9 μU/mL in the X-coating, 17.9 ± 1.1 μU/mL in the Carmeda, and 14.28 ± 0.17 μU/mL in the SMARxT coated tubing. These data support the hypothesis that the insulin binding to the PVC tubing can be reduced by 48% and up to 35% with X-coating and Carmeda, and SMARxT coating, respectively. Therefore, the use of coated CPB systems is justified to reduce CPB-associated hyperglycemia.


Related Articles

  • Biomaterials in cardiopulmonary bypass. Courtney, J.M.; Zhao, X.; Qian, H. // Perfusion;1999, Vol. 14 Issue 4, p263 

    Discusses the clinical use of biomedical materials in cardiopulmonary bypass procedure. Blood response to biomaterials; Information on biomaterials; Process of polymer synthesis and modification.

  • Biomaterial development for cardiopulmonary bypass. Gourlay, T. // Perfusion;Sep2001, Vol. 16 Issue 5, p381 

    Cardiopulmonary bypass (CPB) is dependent on materials foreign to the patient for its successful application. When blood comes into contact with these so-called biomaterials, an inappropriate inflammatory response, which can be life-threatening in some patients, may develop. The reason for this...

  • Does cardiopulmonary bypass still represent a good investment? The biomaterials perspective. Gourlay, T.; Connolly, P. // Perfusion;Jul2003, Vol. 18 Issue 4, p151 

    Cardiopulmonary (CPB) bypass is 50 years old this year, and has undergone considerable change in that time, particularly with regard to developing technology. However, in recent years the routine application of CPB, as the treatment of choice for patients undergoing reparative heart surgery, has...

  • Strategic Leukofiltration in Cardiac Surgery. Gunaydin, S.; McCusker, K.; Vijay, V. // Current Medicinal Chemistry - Cardiovascular & Hematological Age;Oct2005, Vol. 3 Issue 4, p323 

    Systemic inflammatory response syndrome (SIRS) with activation of molecular cascades, cell activation, accumulation of interstitial fluid, organ dysfunction and, occasionally, organ failure is still a commonly recognized consequence of cardiac surgery. SIRS leads to costly complications and...

  • The inflammatory response to cardiopulmonary bypass: a therapeutic overview. Rubens, F.D.; Mesana, T. // Perfusion;Jan2004 Supplement 1, Vol. 19, p5 

    The demographic of cardiac surgery patients continues to evolve to include older, sicker candidates, all the while maintaining an expectation of excellent outcomes. These latter results can only be achieved by the parallel advancement and re-examination of the technology of cardiopulmonary...

  • The impact of different biocompatible coated cardiopulmonary bypass circuits on inflammatory response and oxidative stress. Sohn, N.; Marcoux, J.; Mycyk, T.; Krahn, J.; Meng, Q. H. // Perfusion;Jul2009, Vol. 24 Issue 4, p231 

    This study was to compare the impact of different biocompatible coated circuits on inflammatory response and oxidative stress induced during cardiopulmonary bypass (CPB). Seventy-eight patients undergoing elective coronary artery bypass grafting (CABG) with CPB were randomly assigned to five...

  • Effective blood glucose management in patients with diabetes recovering from CABG. Lehwaldt, Daniela // British Journal of Cardiac Nursing;Apr2011, Vol. 6 Issue 4, p163 

    Nurses are frequently involved in blood glucose monitoring in patients with diabetes recovering from coronary artery bypass grafting (CABG). The goal is to prevent and limit serious postoperative complications associated with hyperglycaemia (increased blood glucose levels) including sternal and...

  • Blood interactions with plasticised poly (vinyl chloride): influence of surface modification. Xiaobin Zhao; Courtney, James M.; Yin, Hua Q.; West, Robin H.; Lowe, G. D. O // Journal of Materials Science: Materials in Medicine;Feb2008, Vol. 19 Issue 2, p713 

    Surface modification of plasticised poly (vinyl chloride) (PVC), with di-(2-ethylhexyl) phthalate (DEHP) as plasticiser, for the improvement of blood compatibility in potential clinical use such as cardiopulmonary bypass was achieved by heparinisation. The influence of surface modification on...

  • 180 ml and less: Cardiopulmonary bypass techniques to minimize hemodilution for neonates and small infants. Charette, Kevin; Hirata, Yasutaka; Bograd, Adam; Mongero, Linda; Chen, Jonathan; Quaegebeur, Jan; Mosca, Ralph // Perfusion;Sep2007, Vol. 22 Issue 5, p327 

    Objective. To determine the efficacy of decreasing cardiopulmonary bypass (CPB) prime volume for neonates and small infants by using low prime oxygenators, small diameter polyvinyl chloride (PVC) tubing and removing the arterial line filter (ALF) in an effort to reduce intraoperative exposure to...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics